CALIXAR acquires the first Monolith X of Nanotemper in France for membrane protein characterization

December 23, 2021

CALIXAR is the first French company to acquire the Monolith X of Nanotemper for ligand binding assays. Thanks to this new equipment, CALIXAR offers to scientists and researchers the possibility to obtain accurate ligand binding parameters and compare several ligands in terms of binding properties.This device is designed with MicroScale Thermophoresis (MST) technology combined with isothermal spectral shift detection, which ensuring interactions between membrane proteins and unlabeled ligands in solution.Thanks to this latest technology, CALIXAR, expert in the production and purification of membrane proteins, completes its analytical capabilities in ligand binding to a wide range of membrane targets (GPCRs, ion channels, transporters, enzymes, …).For more information: Ligand Binding Assays

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.